Cationic Lipid-Polymer Composite for RNP Transfection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering Cas9 RNPs into mammalian cells, particularly pluripotent stem cells and lymphatic cells, are inefficient, especially using lipid-mediated transfection methodologies, which face resistance and low editing efficiency.
Innovation Solution
A composition comprising a ribonucleoprotein complex, a lipid aggregate-forming cationic lipid, and an enhancer element is used to form a cell transfection composition, enhancing the delivery of nucleic acids, proteins, and ribonucleoproteins into cells by forming a stable complex that improves transfection efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If lipid-mediated transfection is used to deliver Cas9 RNPs, then ease of use and cost-effectiveness are improved, but transfection efficiency deteriorates significantly
Solution Approach 1:
The patent combines cationic lipids with polymer components to create composite transfection reagents that maintain the ease of lipid-mediated transfection while significantly improving transfection efficiency through the synergistic effects of both material types
Solution Approach 2:
The patent modifies the chemical parameters of the transfection reagents by incorporating polymers with specific functional groups and charge densities, thereby changing the physical-chemical properties to enhance interaction with Cas9 RNPs and improve cellular uptake efficiency
2Ease of manufacture
If standard lipid-mediated transfection is used, then cost is reduced, but delivery effectiveness into resistant cells deteriorates
Solution Approach 1:
The invention creates composite transfection reagents combining cationic lipids with polymer components, maintaining cost-effectiveness while significantly improving delivery effectiveness into resistant cell types through enhanced complex formation and cellular uptake mechanisms
3Productivity
If electroporation is used to deliver Cas9 RNPs, then transfection efficiency is improved, but ease of use and adaptation to high throughput systems deteriorates
Solution Approach 1:
The patent replaces the mechanical electroporation system with a chemical transfection approach using enhanced lipid-polymer composite reagents, thereby maintaining high transfection efficiency while eliminating the need for specialized equipment and simplifying the procedure for high throughput applications
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach significantly enhances the transfection efficiency of Cas9 RNPs into target cells, overcoming previous resistance issues and achieving high genome editing efficiencies while minimizing off-target effects.
Implementation Method 1
contacting the ribonucleoprotein complex with the lipid aggregate-forming cationic lipid, thereby forming a stable complex
Data Source
AI summary
Provided herein are compositions and methods useful, inter alia, for the delivery of ribonucleoprotein complexes (e.g., Cas9/guide RNA complexes) into cells. The compositions and methods provided herein are particularly useful for the delivery of ribonucleoprotein complexes into pluripotent cells and lymphatic cells.